Image 1
Orphenadrine Citrate Injection
Product Images NDC 0591-3222
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 0591-3222). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Orphenadrine Citrate Injection is a prescription medication that is administered through injection for Intravenous or Intramuscular Use. It is available in Sterile Ampules containing 30mg/mL of the medication. Each 2mL ampule contains different ingredients, including S0 Sodum, Metbiie 091, Sadum CHonde 25, e for et 45, Sodum i ondlo, Hydochiont Aoy, and Grpnensarn Cste. The dosage and price information is not available. The medication is manufactured by Actavis and is only available upon a doctor's prescription.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
